TSLP — Drug Target
All drugs that target TSLP — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Phase 3 pipeline (1)
- Tezepelumab (APFS) · AstraZeneca · IL-33/ST2 pathway inhibitor · Immunology
Tezepelumab is a monoclonal antibody that targets and blocks the activity of thymic stromal lymphopoietin (TSLP), a cytokine involved in the initiation of allergic inflammation.